Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03288714 · ClinicalTrials.gov registry record · NA
Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder
A NA study, sponsored by Wave Neuroscience.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
NCT03288714 is a NA study that has completed, run by Wave Neuroscience. The registered enrollment target is 121 participants.
The verdict
NCT03288714, a NA study, has completed, sponsored by Wave Neuroscience.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
Study Summary
This is a double-blind, sham controlled, multi-center study to confirm the safety and efficacy of synchronized transcranial magnetic stimulation (sTMS) for the treatment of patients currently experiencing an episode of depression who have failed to respond to at least one (1) antidepressant medication. Patients will be randomly assigned to either active or sham therapy and will undergo daily treatments for a period of time. Following completion of blinded treatments, patients may be eligible for a course of open label treatments.
Interventions
- DEVICE Sham Stimulation
- DEVICE Synchronized Transcranial Magnetic Stimulation (sTMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2017-11-27 |
| Est. Completion | 2019-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03288714
The ClinicalTrials.gov registry entry for NCT03288714 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wave Neuroscience, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Stimulation is the first listed.
NCT03288714 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03288714 about?
NCT03288714 is a clinical study titled "Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder". This is a double-blind, sham controlled, multi-center study to confirm the safety and efficacy of synchronized transcranial magnetic stimulation (sTMS) for the treatment of patients currently experiencing an episode of depression who have failed to respond to at least one (1) antidepressant medicati...
What is the current status of trial NCT03288714?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2017-11-27. Estimated completion is 2019-06-01.
What interventions are being tested in trial NCT03288714?
The interventions under investigation include: Sham Stimulation (DEVICE), Synchronized Transcranial Magnetic Stimulation (sTMS) (DEVICE).
Who is sponsoring clinical trial NCT03288714?
This trial is sponsored by Wave Neuroscience, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.